GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Novo Integrated Sciences Inc (NAS:NVOS) » Definitions » Price-to-Tangible-Book

Novo Integrated Sciences (Novo Integrated Sciences) Price-to-Tangible-Book : (As of May. 22, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Novo Integrated Sciences Price-to-Tangible-Book?

As of today (2024-05-22), Novo Integrated Sciences's share price is $0.47735. Novo Integrated Sciences's Tangible Book per Share of Feb. 2024 for the quarter that ended in Feb. 2024 was $-0.03. Hence, Novo Integrated Sciences's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Novo Integrated Sciences's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Novo Integrated Sciences's highest Price to Tangible Book Ratio was 1388.89. The lowest was 6.47. And the median was 47.69.

NVOS's Price-to-Tangible-Book is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 3.2
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Novo Integrated Sciences's share price is $0.47735. Novo Integrated Sciences's Book Value per Sharefor the quarter that ended in Feb. 2024 was $1.25. Hence, Novo Integrated Sciences's P/B Ratio of today is 0.38.


Novo Integrated Sciences Price-to-Tangible-Book Historical Data

The historical data trend for Novo Integrated Sciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Integrated Sciences Price-to-Tangible-Book Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.75 39.76 20.63 - 21.88

Novo Integrated Sciences Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.04 8.20 21.88 63.16 -

Competitive Comparison of Novo Integrated Sciences's Price-to-Tangible-Book

For the Medical Care Facilities subindustry, Novo Integrated Sciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Integrated Sciences's Price-to-Tangible-Book Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Novo Integrated Sciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Novo Integrated Sciences's Price-to-Tangible-Book falls into.



Novo Integrated Sciences Price-to-Tangible-Book Calculation

Novo Integrated Sciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Feb. 2024 )
=0.47735/-0.033
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Novo Integrated Sciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Novo Integrated Sciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Integrated Sciences (Novo Integrated Sciences) Business Description

Traded in Other Exchanges
N/A
Address
11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
Executives
Sarfaraz Ali director C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Robert Letterio Oliva director 115 BELFIELD RD, TORONTO A6 L0J 1C0
Sterling M. Jimenez officer: Principal Financial Officer C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Michael Ross Pope director 1045 PROGRESS CIRCLE, LAWRENCEVILLE, GEORGIA GA 30043
Alex Flesias director 41 LANDMARK COURT, UNIONVILLE A6 L3R 9N7
Michael Joseph Gaynor director 49 BALMORAL ST, KEMPTVILLE A6 K0G 1J0
Robert Mattacchione director, 10 percent owner, officer: Chief Executive Officer 79 SELVAPIANO CRES, WOODBRIDGE A6 L4H 0X1
Pierre Joseph Dalcourt director, 10 percent owner 35 BRYANT ST , BOX 2230, HEARST A6 P0L 1N0
Christopher Mehlin David director, officer: President 10425 SE 22ND ST., BELLEVUE WA 98004
Thomas Edward Bray officer: Principal Financial Officer C/O NOVO INTEGRATED SCIENCES, INC., 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Rebecca Aw Mcdonald officer: Chief Accounting Officer 1301 INTERNATIONAL SPEEDWAY BLVD., DELAND FL 32724
James Jr Teters director 1200 FLIGHTLINE BLVD, STE 5, DELAN FL 32724
Phyllis Rouse officer: secretary 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724
Jay Hilden officer: President & CEO 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724
Robert Adamo director 1200 FLIGHTLINE BOULEVARD, SUITE 5, DELAND FL 32724

Novo Integrated Sciences (Novo Integrated Sciences) Headlines

From GuruFocus

Embracing Technology and Innovation "Key" to Easing Healthcare Crisis

By Business Wire Business Wire 08-09-2022

Novo Integrated Sciences Announces Receipt of Notice from Nasdaq

By Business Wire Business Wire 01-30-2023